Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New anticancer agents claimed by several research groups

Aug. 22, 2007

Enzyme inhibitors identified at Schering-Plough with potential in inflammatory disorders

Aug. 22, 2007

Recent patents cover HDAC inhibitors primarily for cancer

Aug. 21, 2007

Potential new therapies for immunological disorders reported in the patent literature

Aug. 21, 2007

Several series of protein kinase inhibitors claimed for the treatment of cancer

Aug. 20, 2007

PTP-1B inhibitors claimed in recent patent by Metabasis

Aug. 20, 2007

Roche and Schering-Plough separately claim novel compounds for obesity and related disordes

Aug. 16, 2007

Bayer describes new thrombin inhibitors

Aug. 16, 2007

Recent patents cover novel agents for neurologic disorders

Aug. 16, 2007

JAK inhibitors claimed by Vertex for asthma and other conditions

Aug. 14, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...